Minerva Neurosciences (NERV) Total Non-Current Liabilities (2013 - 2026)

Minerva Neurosciences (NERV) has 11 years of Total Non-Current Liabilities data on file, last reported at $283.1 million in Q1 2026.

• Quarterly Total Non-Current Liabilities rose 14437.98% year-over-year to $283.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $283.1 million (up 14437.98% YoY) and the FY2025 annual result came in at $173.8 million, up 176.52% from the prior year.
• Total Non-Current Liabilities improved to $283.1 million in Q1 2026, from $173.8 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $283.1 million in Q1 2026 to a low of $1.4 million in Q4 2022.
• A 5-year average of $32.9 million and a median of $3.2 million in 2022 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities plunged 55.04% — and 2026, when it jumped 14437.98%.
• Tracing NERV's Total Non-Current Liabilities over 5 years: stood at $1.4 million in 2022, then soared by 142.49% to $3.3 million in 2023, then jumped by 1781.11% to $62.8 million in 2024, then jumped by 176.52% to $173.8 million in 2025, then soared by 62.92% to $283.1 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $283.1 million (Q1 2026), $173.8 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.